Month: May 2019

The two T4-T3 ratios that confine thyroid therapy

by thyroidpatientsca, posted in Healthy thyroid axis, Research Reviews, T3-T4 combo-therapy, Thyroid science history

Here are the two most pervasive, limiting, and potentially harmful presumptions about T3:T4 hormone ratios in thyroid science today.   Ratio #1: There is a perfect physiological T4:T3 ratio secreted from the healthy human thyroid gland, and it is approximately 15:1. (Various ratios are cited, most often from 13:1 to 16:1) Ratio #2: In the … Continue reading The two T4-T3 ratios that confine thyroid therapy

CBC opinion article draft on subclinical hypothyroidism and its therapy

by thyroidpatientsca, posted in Diagnosis, Our advocacy, Subclinical thyroid status

I just sent this opinion article draft to the CBC opinion editors by email. --- Dear CBC opinion editors, I would like to offer my opinion piece on this trending topic. First, about me, then the article draft: I am the main researcher and writer for the Canadian Thyroid Patients' Campaign, who launched a federal … Continue reading CBC opinion article draft on subclinical hypothyroidism and its therapy

Subclinical hypothyroidism guidelines delay (in)effective therapy

by thyroidpatientsca, posted in Diagnosis, Subclinical thyroid status, Therapy guidelines

This week, a BBC news article is circulating with the report that "Thyroid disease [is] being over-treated." (May 15, 2019). (1) More specifically, it reported that newly published guidelines claim that "almost all adults with mild or "subclinical" hypothyroidism will not benefit from hormone treatment." In response, thyroid-treated persons who suffer poorly optimized thyroid hormone … Continue reading Subclinical hypothyroidism guidelines delay (in)effective therapy

2014 ATA Therapy guidelines: 4. Using Synthetic T3

by thyroidpatientsca, posted in American Thyroid Association, T3-monotherapy, T3-T4 combo-therapy, Therapy guidelines

This post continues my paraphrase of Jonklaas et al's 2014 "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014 ATA Thyroid therapy guidelines: 2. Ethics2014 ATA Therapy guidelines: 3. Desiccated thyroid2014 ATA Therapy guidelines: … Continue reading 2014 ATA Therapy guidelines: 4. Using Synthetic T3

2014 ATA Therapy guidelines: 3. Desiccated thyroid

by thyroidpatientsca, posted in American Thyroid Association, NDT / Desiccated thyroid, Therapy guidelines, Therapy paradigms, Thyroid pharma

This post continues my paraphrase of Jonklaas et al's 2014 "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014 ATA Thyroid therapy guidelines: 2. Ethics2014 ATA Therapy guidelines: 3. Desiccated thyroid [this post]2014 ATA … Continue reading 2014 ATA Therapy guidelines: 3. Desiccated thyroid